ArticleComputers in biology and medicine2023
Estimate the incubation period of coronavirus 2019 (COVID-19).
Article in Computers in biology and medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Assessing changes in incubation period, serial interval, and generation time of SARS-CoV-2 variants of concern: a systematic review and meta-analysis.BMC medicine · 2023Pooled it
- Comprehensive estimation for the length and dispersion of COVID-19 incubation period: a systematic review and meta-analysis.Infection · 2022Pooled it
- Hospital-onset COVID-19 infection surveillance systems: a systematic review.The Journal of hospital infection · 2021Pooled it
- A history-dependent approach for accurate initial condition estimation in epidemic models.PLoS computational biology · 2025Article
- Overcoming bias in estimating epidemiological parameters with realistic history-dependent disease spread dynamics.Nature communications · 2024Article
- Bayesian Spatio-Temporal Modeling of the Dynamics of COVID-19 Deaths in Peru.Entropy (Basel, Switzerland) · 2024Article
- The effect of COVID-19 on cancer incidences in the U.S.Heliyon · 2024Article
- Article
- Evaluation of the EsteR Toolkit for COVID-19 Decision Support: Sensitivity Analysis and Usability Study.JMIR formative research · 2023Article
- Incubation period for COVID-19: a systematic review and meta-analysis.Zeitschrift fur Gesundheitswissenschaften = Journal of public health · 2022Review
- In pursuit of the right tail for the COVID-19 incubation period.Public health · 2021Review
- Harnessing peak transmission around symptom onset for non-pharmaceutical intervention and containment of the COVID-19 pandemic.Nature communications · 2021Article
- Increasing efficacy of contact-tracing applications by user referrals and stricter quarantining.PloS one · 2021Article
- Aspects of Epidemiology, Pathology, Virology, Immunology, Transmission, Prevention, Prognosis, Diagnosis, and Treatment of COVID-19 Pandemic: A Narrative Review.International journal of preventive medicine · 2021Review
- Characteristics of asymptomatic COVID-19 infection and progression: A multicenter, retrospective study.Virulence · 2020Article
- Race to arsenal COVID-19 therapeutics: Current alarming status and future directions.Chemico-biological interactions · 2020Review
- Viral disease spreading in grouped population.Computer methods and programs in biomedicine · 2020Article
- Epidemiological parameters of COVID-19 and its implication for infectivity among patients in China, 1 January to 11 February 2020.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2020Article
- Meta-analysis of several epidemic characteristics of COVID-19.Journal of data science : JDS · 2020Article
- Meta-analysis of several epidemic characteristics of COVID-19.medRxiv : the preprint server for health sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 is an infectious disease that presents unprecedented challenges to society. Accurately estimating the incubation period of the coronavirus is critical for effective prevention and control. However, the exact incubation period remains unclear, as COVID-19 symptoms can appear in as little as 2 days or as long as 14 days or more after exposure. Accurate estimation requires original chain-of-infection data, which may not be fully available from the original outbreak in Wuhan, China. In this study, we estimated the incubation period of COVID-19 by leveraging well-documented and epidemiologically informative chain-of-infection data collected from 10 regions outside the original Wuhan areas prior to February 10, 2020. We employed a proposed Monte Carlo simulation approach and nonparametric methods to estimate the incubation period of COVID-19. We also utilized manifold learning and related statistical analysis to uncover incubation relationships between different age and gender groups. Our findings revealed that the incubation period of COVID-19 did not follow general distributions such as lognormal, Weibull, or Gamma. Using proposed Monte Carlo simulations and nonparametric bootstrap methods, we estimated the mean and median incubation periods as 5.84 (95% CI, 5.42-6.25 days) and 5.01 days (95% CI 4.00-6.00 days), respectively. We also found that the incubation periods of groups with ages greater than or equal to 40 years and less than 40 years demonstrated a statistically significant difference. The former group had a longer incubation period and a larger variance than the latter, suggesting the need for different quarantine times or medical intervention strategies. Our machine-learning results further demonstrated that the two age groups were linearly separable, consistent with previous statistical analyses. Additionally, our results indicated that the incubation period difference between males and females was not statistically significant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.